Large-Dose Propofol During Cardiopulmonary Bypass Decreases Biochemical Markers of Myocardial Injury in Coronary Surgery Patients: A Comparison with Isoflurane
- 1 September 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 103 (3) , 527-532
- https://doi.org/10.1213/01.ane.0000230612.29452.a6
Abstract
We investigated if increasing propofol's dosage to augment its antioxidant capacity during cardiopulmonary bypass (CPB) could confer cardiac protection. Fifty-four coronary artery bypass graft surgery patients were randomly assigned to small-dose propofol (Group P; n = 18), large-dose propofol (Group HiP; n = 18), or isoflurane Group (Group I; n = 18). After the induction, anesthesia was maintained with an inspired concentration of isoflurane 1%-3.5% (Group I) or a continuous infusion of propofol 60 microg x kg(-1) x min(-1) (Group P) throughout the surgery. In Group HiP, this dose of propofol was increased to 120 microg x kg(-1) x min(-1) for 10 min before the onset of CPB until 15 min after aortic unclamping and then decreased to 60 microg x kg(-1) x min(-1) until the end of surgery. The duration of aortic cross-clamping was 83 +/- 24, 88 +/- 22, and 81 +/- 20 min in Group P, Group HiP, and Group I, respectively (P > 0.1). Plasma malondialdehyde, a marker of oxidative stress, was significantly lower at 8 h after CPB, and Troponin I was lower at 24 h after CPB in Group HiP compared with Group P and Group I (P < 0.05). There was a significant reduction in inotropic requirements for separation from CPB in Group HiP compared with Group I. Postoperative systemic vascular resistance was significantly reduced in Group HiP as compared with Group I. Mean cardiac index was significantly higher at 24 h after CPB in Group HiP compared with Group P and Group I (P < 0.05) (Group I, 2.2 +/- 0.1; Group P, 2.3 +/- 0.2; and Group HiP, 2.8 +/- 0.3 L x min(-1) x m(-2), respectively). The duration of intensive care unit stay was significantly shorter in Group Hi-P compared with Group I. We conclude that administration of a large dose of propofol during CPB attenuates postoperative myocardial cellular damage as compared with isoflurane or small-dose propofol anesthesia.Keywords
This publication has 30 references indexed in Scilit:
- Propofol Dose-Dependently Reduces Tumor Necrosis Factor-??-Induced Human Umbilical Vein Endothelial Cell Apoptosis: Effects on Bcl-2 and Bax Expression and Nitric Oxide GenerationAnesthesia & Analgesia, 2005
- Anesthetic Preconditioning: The Role of Free Radicals in Sevoflurane-Induced Attenuation of Mitochondrial Electron Transport in Guinea Pig Isolated HeartsAnesthesia & Analgesia, 2005
- Application of high-dose propofol during ischemia improves postischemic function of rat hearts: effects on tissue antioxidant capacityCanadian Journal of Physiology and Pharmacology, 2004
- Isoflurane may not influence postoperative cardiac troponin I release and clinical outcome in adult cardiac surgeryEuropean Journal of Anaesthesiology, 2004
- Tumor Necrosis Factor Gene Polymorphism Is Associated with Enhanced Systemic Inflammatory Response and Increased Cardiopulmonary Morbidity After Cardiac SurgeryAnesthesia & Analgesia, 2003
- Anesthetic PreconditioningAnesthesiology, 2003
- Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formationCanadian Journal of Physiology and Pharmacology, 2003
- Propofol Improves Functional and Metabolic Recovery in Ischemic Reperfused Isolated Rat HeartsAnesthesia & Analgesia, 1998
- Propofol Attenuates Ischemia-Reperfusion Injury in the Isolated Rat HeartAnesthesia & Analgesia, 1997
- Study design in clinical research: sample size estimation and power analysisCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1996